Inhalerx Health Care
Biotech Cancer Healthcare Medical

$0.040 -0.008 (-16.67%)

High $0.04	Low $0.04	Trades 4	Turnover $6,750	Volume 172,500
30 June 2023 at 3:09pm

If you were already registered, log in here.

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code IRX	Name Inhalerx Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Health Care Equipment & Services	GIC Industry Health Care Equipment & Supplies	GIC Sub Industry Health Care Equipment
Sector Healthcare	IPO Date N/A	Fiscal Year December	Type Common Stock
Shares Outstanding 246,257,323	Shares Floated 89,466,823	Held by Insiders 60.525%	Held by Institutions 0%

Directors & Officers

Name & Education	Position
Mr. Darryl Davies B.Sc.	Chief Executive Officer
Dr. Robert Jenny B.A., B.Sc., Ph.D.	Chief Scientific Officer
Greg Hammond	Chief Financial Officer
Mr. Srinivasa Rao Suryadevara	Executive Vice President

IRX Historic Dividends

Date	Amount
We found no dividends on record for IRX.

If you were already registered, log in here.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.03	52,208	-0.01 (22.22%)
12-Sep	$0.04	25,650	0.00 (7.69%)
11-Sep	$0.04	0	+0.01 (18.18%)
05-Sep	$0.03	200,000	0.00 (5.71%)
04-Sep	$0.04	0	0.00 (0.00%)
03-Sep	$0.04	0	0.00 (0.00%)
29-Aug	$0.04	32,000	+0.00 (12.90%)
28-Aug	$0.03	67,027	0.00 (11.43%)
22-Aug	$0.04	75,000	0.00 (0.00%)
21-Aug	$0.04	125,000	0.00 (5.41%)
15-Aug	$0.04	0	0.00 (0.00%)
14-Aug	$0.04	4,300	0.00 (7.50%)
07-Aug	$0.04	32,705	0.00 (4.76%)
31-Jul	$0.04	23,809	0.00 (4.55%)
30-Jul	$0.04	0	0.00 (0.00%)
2 up, 8 down, and 5 flat days

Market Cap (19-Sep) $5,976,544	EBITDA -	PE 0.00	Book Value $0.00
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.01	Profit Margin N/A
Operating Margin -143.46%	ROA 86.5%	ROE 402.12%	Revenue (FY) $833,899
Revenue per Share $0.00	Gross Profit (FY) $833,899	Q' YOY Revenue Growth 345.6%	Q' YOY Earnings Growth -

Inhalerx Health Care
Biotech Cancer Healthcare Medical

Stock Information

Technicals

Financial Snapshot (June 2025)

Directors & Officers

IRX Historic Dividends

Followers

Prices

Announcements

End of Day Prices

IRX Inhalerx Health Care Biotech Cancer Healthcare Medical

Stock Information

Technicals

Financial Snapshot (June 2025)

Directors & Officers

IRX Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Inhalerx Health Care
Biotech Cancer Healthcare Medical